Farallon Capital Management
Latest statistics and disclosures from Farallon Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, RVMD, MSFT, AMZN, AON, and represent 29.53% of Farallon Capital Management's stock portfolio.
- Added to shares of these 10 stocks: CYBR (+$470M), SNPS (+$469M), AVGO (+$309M), KKR (+$257M), BSX (+$257M), AMZN (+$230M), Ceridian Hcm Hldg (+$202M), BITW (+$199M), MSFT (+$146M), AON (+$137M).
- Started 27 new stock positions in CELC, ETH, VSTM, ADPT, WELL, KKR, PCVX, NERV, CYBR, BITW.
- Reduced shares in these 10 stocks: HYG (-$2.5B), ADSK (-$528M), TMO (-$361M), TRU (-$348M), INTU (-$333M), K (-$324M), ADI (-$319M), CRM (-$318M), RSP (-$287M), SPY (-$273M).
- Sold out of its positions in ALE, ADI, ADSK, NTLA, INTU, IQV, SOXX, K, MARA, Mr Cooper Group. NKTR, NSC, SVRA, SGRY, TECX, RARE, WAY, WWD, FLUT, GDLC, MRUS.
- Farallon Capital Management was a net seller of stock by $-4.8B.
- Farallon Capital Management has $21B in assets under management (AUM), dropping by -13.25%.
- Central Index Key (CIK): 0000909661
Tip: Access up to 7 years of quarterly data
Positions held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 150 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 9.7 | $2.0B | -11% | 3.0M | 681.92 |
|
| Revolution Medicines (RVMD) | 5.5 | $1.2B | 15M | 79.65 |
|
|
| Microsoft Corporation (MSFT) | 5.1 | $1.1B | +15% | 2.2M | 483.62 |
|
| Amazon (AMZN) | 4.9 | $1.0B | +28% | 4.5M | 230.82 |
|
| Aon Shs Cl A (AON) | 4.4 | $941M | +16% | 2.7M | 352.88 |
|
| Natera (NTRA) | 4.2 | $897M | -7% | 3.9M | 229.09 |
|
| Boston Scientific Corporation (BSX) | 3.3 | $709M | +56% | 7.4M | 95.35 |
|
| Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP) | 3.3 | $690M | -29% | 3.6M | 191.56 |
|
| Exelixis (EXEL) | 3.2 | $689M | -19% | 16M | 43.83 |
|
| Bridgebio Pharma (BBIO) | 3.2 | $688M | +9% | 9.0M | 76.49 |
|
| Ishares Tr Iboxx Hi Yd Etf Put Option (HYG) | 3.0 | $645M | -79% | 8.0M | 80.63 |
|
| Protagonist Therapeutics (PTGX) | 2.5 | $537M | 6.1M | 87.34 |
|
|
| Wabtec Corporation (WAB) | 2.5 | $529M | +12% | 2.5M | 213.45 |
|
| UnitedHealth (UNH) | 2.5 | $528M | -15% | 1.6M | 330.11 |
|
| Cyberark Software SHS (CYBR) | 2.2 | $470M | NEW | 1.1M | 446.06 |
|
| Walt Disney Company (DIS) | 2.2 | $469M | -20% | 4.1M | 113.77 |
|
| Synopsys (SNPS) | 2.2 | $469M | NEW | 999k | 469.72 |
|
| Eli Lilly & Co. Put Option (LLY) | 1.9 | $403M | 375k | 1074.68 |
|
|
| Thermo Fisher Scientific (TMO) | 1.7 | $368M | -49% | 636k | 579.45 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.7 | $361M | +56% | 5.4M | 66.55 |
|
| Aramark Hldgs (ARMK) | 1.6 | $345M | +4% | 9.4M | 36.86 |
|
| salesforce (CRM) | 1.6 | $334M | -48% | 1.3M | 264.91 |
|
| Charles Schwab Corporation (SCHW) | 1.6 | $334M | +2% | 3.3M | 99.91 |
|
| Crinetics Pharmaceuticals In (CRNX) | 1.5 | $323M | +20% | 6.9M | 46.55 |
|
| Broadcom (AVGO) | 1.5 | $309M | NEW | 892k | 346.10 |
|
| Liquidia Corporation Com New (LQDA) | 1.4 | $299M | 8.7M | 34.49 |
|
|
| Nasdaq Omx (NDAQ) | 1.4 | $290M | -17% | 3.0M | 97.13 |
|
| Beam Therapeutics (BEAM) | 1.3 | $279M | 10M | 27.72 |
|
|
| Kkr & Co (KKR) | 1.2 | $257M | NEW | 2.0M | 127.48 |
|
| Alphabet Cap Stk Cl C (GOOG) | 1.2 | $247M | -29% | 787k | 313.80 |
|
| McKesson Corporation (MCK) | 1.2 | $245M | -8% | 299k | 820.29 |
|
| Visa Com Cl A (V) | 1.2 | $244M | +16% | 696k | 350.71 |
|
| New York Times Cl A (NYT) | 1.1 | $228M | -34% | 3.3M | 69.42 |
|
| Ceridian Hcm Hldg | 1.0 | $202M | NEW | 2.9M | 69.16 |
|
| Grail (GRAL) | 0.9 | $201M | +73% | 2.3M | 85.59 |
|
| Bitwise 10 Crypto Index Etf Unit Beneficial (BITW) | 0.9 | $199M | NEW | 3.4M | 58.76 |
|
| Cbre Group Cl A (CBRE) | 0.7 | $158M | -39% | 984k | 160.79 |
|
| Agios Pharmaceuticals (AGIO) | 0.7 | $140M | -10% | 5.2M | 27.22 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.6 | $135M | +24% | 5.4M | 25.01 |
|
| Beta Bionics (BBNX) | 0.6 | $131M | 4.3M | 30.47 |
|
|
| Cardinal Health (CAH) | 0.6 | $118M | +127% | 576k | 205.50 |
|
| Tango Therapeutics (TNGX) | 0.5 | $116M | +21% | 13M | 8.86 |
|
| Hims & Hers Health Com Cl A (HIMS) | 0.5 | $110M | -68% | 3.4M | 32.47 |
|
| Ishares Bitcoin Trust Etf Shs Ben Int (IBIT) | 0.5 | $106M | -69% | 2.1M | 49.65 |
|
| Mastercard Incorporated Cl A (MA) | 0.5 | $99M | -19% | 173k | 570.88 |
|
| Cidara Therapeutics Com New (CDTX) | 0.4 | $85M | -24% | 383k | 220.89 |
|
| Tenet Healthcare Corp Com New (THC) | 0.3 | $74M | -10% | 372k | 198.72 |
|
| Welltower Inc Com reit (WELL) | 0.3 | $64M | NEW | 343k | 185.61 |
|
| Transunion (TRU) | 0.3 | $58M | -85% | 675k | 85.75 |
|
| Tyra Biosciences (TYRA) | 0.3 | $54M | +80% | 2.1M | 26.29 |
|
| Vnet Group Sponsored Ads A (VNET) | 0.3 | $53M | +14% | 6.3M | 8.46 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.2 | $52M | -51% | 387k | 134.85 |
|
| Insmed Com Par $.01 (INSM) | 0.2 | $44M | +8333% | 253k | 174.04 |
|
| Enanta Pharmaceuticals (ENTA) | 0.2 | $44M | +30% | 2.8M | 15.77 |
|
| Assembly Biosciences Com New (ASMB) | 0.2 | $42M | 1.2M | 34.01 |
|
|
| Baidu Spon Adr Rep A (BIDU) | 0.2 | $41M | +51% | 315k | 130.66 |
|
| Alnylam Pharmaceuticals Put Option (ALNY) | 0.2 | $40M | 100k | 397.65 |
|
|
| Joyy Ads Repstg Com A (JOYY) | 0.2 | $37M | -7% | 578k | 64.76 |
|
| Ishares Ethereum Tr SHS (ETHA) | 0.2 | $33M | -80% | 1.5M | 22.43 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.1 | $32M | NEW | 454k | 69.55 |
|
| Mineralys Therapeutics (MLYS) | 0.1 | $30M | -50% | 823k | 36.29 |
|
| Sunococorp Com Shs Llc (SUNC) | 0.1 | $30M | NEW | 606k | 49.28 |
|
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.1 | $29M | NEW | 2.3M | 13.03 |
|
| Terns Pharmaceuticals (TERN) | 0.1 | $26M | NEW | 642k | 40.40 |
|
| Encompass Health Corp (EHC) | 0.1 | $25M | -58% | 235k | 106.14 |
|
| Amkor Technology (AMKR) | 0.1 | $18M | NEW | 464k | 39.48 |
|
| Verastem Com New (VSTM) | 0.1 | $15M | NEW | 2.0M | 7.72 |
|
| Doximity Cl A (DOCS) | 0.1 | $14M | -16% | 311k | 44.28 |
|
| Guardant Health (GH) | 0.1 | $11M | +1262% | 109k | 102.14 |
|
| Medline Com Cl A (MDLN) | 0.1 | $11M | NEW | 260k | 42.00 |
|
| New Oriental Ed & Technology Spon Adr (EDU) | 0.1 | $11M | -65% | 196k | 55.03 |
|
| Minerva Neurosciences Com New (NERV) | 0.0 | $9.5M | NEW | 2.4M | 4.02 |
|
| Genedx Holdings Corp Com Cl A (WGS) | 0.0 | $9.1M | +1300% | 70k | 130.06 |
|
| Grayscale Ethereum Mini Tr E Shs New (ETH) | 0.0 | $6.4M | NEW | 228k | 28.06 |
|
| Prime Medicine (PRME) | 0.0 | $4.3M | -73% | 1.2M | 3.47 |
|
| Oscar Health Cl A (OSCR) | 0.0 | $3.8M | -92% | 264k | 14.37 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $1.9M | 3.3k | 582.34 |
|
|
| Summit Midstream Corporation (SMC) | 0.0 | $1.6M | 58k | 26.68 |
|
|
| Novavax Com New (NVAX) | 0.0 | $1.3M | -75% | 195k | 6.72 |
|
| Schrodinger (SDGR) | 0.0 | $1.3M | -75% | 71k | 17.88 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.0 | $1.2M | -99% | 40k | 31.21 |
|
| Capricor Therapeutics Com New (CAPR) | 0.0 | $1.2M | 41k | 28.86 |
|
|
| Arrowhead Pharmaceuticals (ARWR) | 0.0 | $1.0M | 16k | 66.39 |
|
|
| Alvotech Ordinary Shares (ALVO) | 0.0 | $1.0M | 200k | 5.13 |
|
|
| Brightspring Health Svcs (BTSG) | 0.0 | $824k | 22k | 37.45 |
|
|
| Roivant Sciences SHS (ROIV) | 0.0 | $803k | 37k | 21.70 |
|
|
| Arcutis Biotherapeutics (ARQT) | 0.0 | $755k | 26k | 29.04 |
|
|
| Axsome Therapeutics (AXSM) | 0.0 | $731k | 4.0k | 182.64 |
|
|
| Cogent Biosciences (COGT) | 0.0 | $604k | 17k | 35.52 |
|
|
| Alkermes SHS (ALKS) | 0.0 | $582k | 21k | 27.98 |
|
|
| Krystal Biotech (KRYS) | 0.0 | $493k | 2.0k | 246.54 |
|
|
| Progyny (PGNY) | 0.0 | $462k | 18k | 25.68 |
|
|
| Travere Therapeutics (TVTX) | 0.0 | $459k | 12k | 38.21 |
|
|
| Healthequity (HQY) | 0.0 | $458k | 5.0k | 91.61 |
|
|
| Celcuity (CELC) | 0.0 | $399k | NEW | 4.0k | 99.74 |
|
| Omeros Corporation (OMER) | 0.0 | $395k | NEW | 23k | 17.18 |
|
| Ionis Pharmaceuticals (IONS) | 0.0 | $380k | 4.8k | 79.11 |
|
|
| Livanova SHS (LIVN) | 0.0 | $369k | 6.0k | 61.53 |
|
|
| Globus Med Cl A (GMED) | 0.0 | $349k | 4.0k | 87.31 |
|
|
| AmerisourceBergen (COR) | 0.0 | $338k | 1.0k | 337.75 |
|
|
| Uniqure Nv SHS (QURE) | 0.0 | $335k | -97% | 14k | 23.93 |
|
| Beone Medicines Sponsored Ads (ONC) | 0.0 | $334k | 1.1k | 303.81 |
|
|
| Cg Oncology (CGON) | 0.0 | $332k | 8.0k | 41.52 |
|
|
| Scholar Rock Hldg Corp (SRRK) | 0.0 | $308k | 7.0k | 44.05 |
|
|
| Immunovant (IMVT) | 0.0 | $305k | 12k | 25.42 |
|
|
| Nuvalent Inc-a (NUVL) | 0.0 | $302k | 3.0k | 100.59 |
|
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.0 | $299k | 1.4k | 213.24 |
|
|
| Veracyte (VCYT) | 0.0 | $295k | 7.0k | 42.10 |
|
|
| Glaukos (GKOS) | 0.0 | $294k | 2.6k | 112.91 |
|
|
| Solid Power *w Exp 12/08/202 (SLDPW) | 0.0 | $287k | 405k | 0.71 |
|
|
| Stoke Therapeutics (STOK) | 0.0 | $286k | NEW | 9.0k | 31.74 |
|
| Sabra Health Care REIT (SBRA) | 0.0 | $265k | 14k | 18.94 |
|
|
| Merit Medical Systems (MMSI) | 0.0 | $264k | 3.0k | 88.14 |
|
|
| Grifols S A Sp Adr Rep B Nvt (GRFS) | 0.0 | $262k | 28k | 9.35 |
|
|
| Arcellx Common Stock (ACLX) | 0.0 | $261k | 4.0k | 65.20 |
|
|
| Nuvation Bio Com Cl A (NUVB) | 0.0 | $260k | NEW | 29k | 8.96 |
|
| Urogen Pharma (URGN) | 0.0 | $258k | 11k | 23.42 |
|
|
| Pacific Biosciences of California (PACB) | 0.0 | $253k | 135k | 1.87 |
|
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.0 | $246k | 3.0k | 82.02 |
|
|
| Twist Bioscience Corp (TWST) | 0.0 | $243k | 7.7k | 31.72 |
|
|
| Mirum Pharmaceuticals (MIRM) | 0.0 | $237k | 3.0k | 78.99 |
|
|
| Soleno Therapeutics (SLNO) | 0.0 | $232k | -96% | 5.0k | 46.30 |
|
| Vaxcyte (PCVX) | 0.0 | $231k | NEW | 5.0k | 46.14 |
|
| Amicus Therapeutics (FOLD) | 0.0 | $228k | 16k | 14.24 |
|
|
| Neogenomics Com New (NEO) | 0.0 | $223k | NEW | 19k | 11.76 |
|
| Aleanna Com Cl A (ANNA) | 0.0 | $223k | 78k | 2.85 |
|
|
| Icon SHS (ICLR) | 0.0 | $219k | 1.2k | 182.22 |
|
|
| Establishment Labs Holdings Ord (ESTA) | 0.0 | $219k | NEW | 3.0k | 72.88 |
|
| Ocular Therapeutix (OCUL) | 0.0 | $219k | NEW | 18k | 12.14 |
|
| Syndax Pharmaceuticals (SNDX) | 0.0 | $210k | 10k | 21.01 |
|
|
| Precigen (PGEN) | 0.0 | $209k | NEW | 50k | 4.18 |
|
| Healthcare Rlty Tr Cl A Com (HR) | 0.0 | $203k | 12k | 16.95 |
|
|
| Dyne Therapeutics (DYN) | 0.0 | $196k | 10k | 19.56 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 0.0 | $187k | 24k | 7.80 |
|
|
| Tvardi Therapeutics (TVRD) | 0.0 | $186k | 43k | 4.30 |
|
|
| Adaptive Biotechnologies Cor (ADPT) | 0.0 | $179k | NEW | 11k | 16.24 |
|
| Aleanna *w Exp 12/13/202 (ANNAW) | 0.0 | $164k | 990k | 0.17 |
|
|
| Ardelyx (ARDX) | 0.0 | $134k | 23k | 5.83 |
|
|
| Blue Gold *w Exp 04/01/203 (BGLWW) | 0.0 | $132k | 300k | 0.44 |
|
|
| Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.0 | $113k | 120k | 0.94 |
|
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.0 | $105k | NEW | 78k | 1.35 |
|
| Altimmune Com New (ALT) | 0.0 | $100k | 28k | 3.61 |
|
|
| Iovance Biotherapeutics (IOVA) | 0.0 | $71k | 26k | 2.73 |
|
|
| Geron Corporation (GERN) | 0.0 | $57k | 43k | 1.32 |
|
|
| Evolent Health Cl A (EVH) | 0.0 | $56k | 14k | 4.00 |
|
|
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $54k | 28k | 1.91 |
|
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $44k | 13k | 3.37 |
|
|
| Canopy Growth Corp Com New (CGC) | 0.0 | $34k | 30k | 1.14 |
|
|
| Nvni Group *w Exp 11/01/202 (NVNIW) | 0.0 | $23k | 375k | 0.06 |
|
|
| Beyond Meat (BYND) | 0.0 | $16k | 19k | 0.82 |
|
Past Filings by Farallon Capital Management
SEC 13F filings are viewable for Farallon Capital Management going back to 2010
- Farallon Capital Management 2024 Q4 amended filed Feb. 17, 2026
- Farallon Capital Management 2025 Q1 amended filed Feb. 17, 2026
- Farallon Capital Management 2025 Q2 amended filed Feb. 17, 2026
- Farallon Capital Management 2025 Q3 restated filed Feb. 17, 2026
- Farallon Capital Management 2025 Q4 filed Feb. 17, 2026
- Farallon Capital Management 2023 Q3 amended filed Nov. 14, 2025
- Farallon Capital Management 2023 Q4 amended filed Nov. 14, 2025
- Farallon Capital Management 2024 Q1 amended filed Nov. 14, 2025
- Farallon Capital Management 2024 Q2 amended filed Nov. 14, 2025
- Farallon Capital Management 2024 Q3 amended filed Nov. 14, 2025
- Farallon Capital Management 2024 Q4 amended filed Nov. 14, 2025
- Farallon Capital Management 2025 Q1 amended filed Nov. 14, 2025
- Farallon Capital Management 2025 Q2 amended filed Nov. 14, 2025
- Farallon Capital Management 2025 Q3 filed Nov. 14, 2025
- Farallon Capital Management 2024 Q3 amended filed Aug. 14, 2025
- Farallon Capital Management 2024 Q1 amended filed Aug. 14, 2025